BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 31550502)

  • 1. Drug repurposing for breast cancer therapy: Old weapon for new battle.
    Aggarwal S; Verma SS; Aggarwal S; Gupta SC
    Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges.
    Malik JA; Ahmed S; Jan B; Bender O; Al Hagbani T; Alqarni A; Anwar S
    Biomed Pharmacother; 2022 Jan; 145():112375. PubMed ID: 34863612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing-an emerging strategy in cancer therapeutics.
    Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics.
    Singhal S; Maheshwari P; Krishnamurthy PT; Patil VM
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2726-2756. PubMed ID: 35301945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old drugs, new uses: Drug repurposing in hematological malignancies.
    Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
    Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing of drugs for triple negative breast cancer: an overview.
    Spini A; Donnini S; Pantziarka P; Crispino S; Ziche M
    Ecancermedicalscience; 2020; 14():1071. PubMed ID: 32728387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
    Chen H; Wu J; Gao Y; Chen H; Zhou J
    Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline-a review.
    Siddiqui S; Deshmukh AJ; Mudaliar P; Nalawade AJ; Iyer D; Aich J
    J Egypt Natl Canc Inst; 2022 Aug; 34(1):33. PubMed ID: 35934727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review.
    Selvaraj J; Prabha T; Yadav N
    Curr Drug Res Rev; 2021; 13(1):3-15. PubMed ID: 32838729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational method for drug repositioning using publicly available gene expression data.
    Shabana KM; Abdul Nazeer KA; Pradhan M; Palakal M
    BMC Bioinformatics; 2015; 16 Suppl 17(Suppl 17):S5. PubMed ID: 26679199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.